GlassScriptPhysician profile
Cara M Hartquist
NPI 1619317997
$2,194.24
in general payments reported to CMS, 2019-2025
24 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,465 · 2020: $390 · 2021: $67.21 · 2024: $19.99 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $252.46 | 2025 | |
| Amgen INC. | $244.71 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $196.36 | 2019-2020 | |
| Pfizer INC. | $191.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $181.53 | 2019-2020 | |
| Astellas Pharma US INC | $148.08 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.83 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.06 | 2019-2020 | |
| Lilly USA, LLC | $118.93 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $92.57 | 2019-2020 | |
| Novo Nordisk INC | $87.35 | 2019-2021 | |
| Amarin Pharma, INC. | $50.56 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $47.64 | 2019 | |
| Melinta Therapeutics, LLC | $44.97 | 2019 | |
| Radius Health, INC. | $44.67 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $40.67 | 2019 | |
| Merck Sharp & Dohme LLC | $27.13 | 2020 | |
| Mylan Specialty L.P. | $26.81 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $26.69 | 2019-2020 | |
| Philips North America LLC | $19.99 | 2024 | (Ck7) Extended Holter |
| Allergan, INC. | $17.48 | 2019 | |
| Evoke Pharma, INC. | $17.26 | 2020 | |
| Ironshore Pharmaceuticals INC. | $16.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Hartquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.